New pill tested to tame painful gout flares

NCT ID NCT03934099

Completed Disease control Sponsor: LG Chem Source: ClinicalTrials.gov ↗

Summary

This study tested whether a new drug called LC350189 could safely lower high uric acid levels in people with gout. For 12 weeks, 156 participants received one of three different doses of the drug, a placebo (a dummy pill), or an existing gout medicine. The main goal was to see how many people could get their uric acid down to a healthy target level.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Advanced Clinical Research

West Jordan, Utah, 84088, United States
Altoona Center For Clinical Research

Duncansville, Pennsylvania, 16635, United States
Avant Research Associates

Austin, Texas, 78704, United States
Avita Clinical Trials

Tampa, Florida, 33613, United States
Clinical Research Trials of Florida, Inc

Tampa, Florida, 33607, United States
Discovery MM Services Incorporated

Houston, Texas, 77450, United States
Dominion Medical Associates

Richmond, Virginia, 23219, United States
Health Awareness Inc

Jupiter, Florida, 33458, United States
IACT Health

Columbus, Georgia, 31904, United States
Meridien Research

Maitland, Florida, 32751, United States
Meridien Research

St. Petersburg, Florida, 33709, United States
Miami Dade Medical Research Institute

Miami, Florida, 33176, United States
Olive Branch Family Medical Cente

Olive Branch, Mississippi, 38654, United States
OnSite Clinical Solutions

Charlotte, North Carolina, 28226, United States
OnSite Clinical Solutions

Charlotte, North Carolina, 28277, United States
Paramount Medical Research and Consulting

Middleburg Heights, Ohio, 44130, United States
Preferred Research Partner

Little Rock, Arkansas, 72211, United States
Quality Clinical Research

Omaha, Nebraska, 68114, United States
Synexus Clinical Research

Birmingham, Alabama, 35211, United States
Synexus Clinical Research

Chandler, Arizona, 85224, United States
Synexus Clinical Research

Mesa, Arizona, 85206, United States
Synexus Clinical Research

Tucson, Arizona, 85712, United States
Synexus Clinical Research

Chicago, Illinois, 60602, United States
Synexus Clinical Research

Richfield, Minnesota, 55423, United States
Synexus Clinical Research

St Louis, Missouri, 63141, United States
Synexus Clinical Research

Omaha, Nebraska, 68144, United States
Synexus Clinical Research

Henderson, Nevada, 89052, United States
Synexus Clinical Research

Akron, Ohio, 44311, United States
Synexus Clinical Research

Cincinnati, Ohio, 45236, United States
Synexus Clinical Research

Columbus, Ohio, 43212, United States
Synexus Clinical Research

Anderson, South Carolina, 29621, United States
Synexus Clinical Research

Dallas, Texas, 75234, United States
Synexus Clinical Research

San Antonio, Texas, 78229, United States
Synexus Clinical Research

Salt Lake City, Utah, 84123, United States

Conditions

Explore the condition pages connected to this study.

GOUT HYPERURICEMIA